======= SARDH ======= == Gene Information == * **Official Symbol**: SARDH * **Official Name**: sarcosine dehydrogenase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=1757|1757]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UL12|Q9UL12]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SARDH&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SARDH|Open PubMed]] * **OMIM**: [[https://omim.org/entry/604455|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes an enzyme localized to the mitochondrial matrix which catalyzes the oxidative demethylation of sarcosine. This enzyme is distinct from another mitochondrial matrix enzyme, dimethylglycine dehydrogenase, which catalyzes a reaction resulting in the formation of sarcosine. Mutations in this gene are associated with sarcosinemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Oct 2008]. * **UniProt Summary**: N/A |GCV T C| |GCV T| |DAO| |sarcosine catabolic process| |sarcosine dehydrogenase activity| |sarcosine metabolic process| |choline catabolic process| |choline metabolic process| |amine catabolic process| |cellular biogenic amine catabolic process| |neurotransmitter catabolic process| |cellular modified amino acid catabolic process| |cellular biogenic amine metabolic process| |cellular amine metabolic process| |amine metabolic process| |neurotransmitter metabolic process| |alpha-amino acid catabolic process| |oxidoreductase activity| |cellular amino acid catabolic process| |ammonium ion metabolic process| |cellular modified amino acid metabolic process| |alpha-amino acid metabolic process| |carboxylic acid catabolic process| |organic acid catabolic process| |cellular amino acid metabolic process| |regulation of neurotransmitter levels| |mitochondrial matrix| |small molecule catabolic process| |carboxylic acid metabolic process| |oxidation-reduction process| |oxoacid metabolic process| |organic acid metabolic process| |organonitrogen compound catabolic process| |mitochondrion| |small molecule metabolic process| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp492|iCRT14 30μM R08 exp492]]|-1.95| |[[:results:exp391|Pomalidomide 20μM R07 exp391]]|-1.78| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|1.93| |[[:results:exp94|Nocodazole 0.1μM R03 exp94]]|2.3| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 4827 * **Expression level (log2 read counts)**: 3.61 {{:chemogenomics:nalm6 dist.png?nolink |}}